Evidence map›Paper›PMID 39251781›Full record

ArticleCellular & molecular immunology2024

RBM25 is required to restrain inflammation via ACLY RNA splicing-dependent metabolism rewiring.

Yunkai Zhang, Ying Gao, Yujia Wang, Yuyu Jiang, Yan Xiang, Xiaohui Wang, Zeting Wang, Yingying Ding, Huiying Chen, Bing Rui and 7 more

Abstract read
In one paragraph

Article in Cellular & molecular immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Research progress on lysine acetylation (Review).International journal of molecular medicine · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Yunkai Zhang *Naval Medical Center, Naval Medical University, Shanghai, 200433, China.
Ying Gao *Department of Rheumatology, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
Yujia WangDepartment of Immunology, Center for Immunotherapy, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, 100730, China.
Yuyu JiangDepartment of Pathogen Biology, Naval Medical University, Shanghai, 200433, China.
Yan XiangDepartment of Pathogen Biology, Naval Medical University, Shanghai, 200433, China.
Xiaohui WangDepartment of Pathogen Biology, Naval Medical University, Shanghai, 200433, China.
Zeting WangDepartment of Pathogen Biology, Naval Medical University, Shanghai, 200433, China.
Yingying DingNational Key Laboratory of Immunity & Inflammation, Naval Medical University, Shanghai, 200433, China.
Huiying ChenNational Key Laboratory of Immunity & Inflammation, Naval Medical University, Shanghai, 200433, China.
Bing RuiNational Key Laboratory of Immunity & Inflammation, Naval Medical University, Shanghai, 200433, China.
Wanwan HuaiDepartment of Immunology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
Boyu CaiDepartment of Otolaryngology, Changzheng Hospital, Naval Medical University, Shanghai, 200003, China.
Xiaomeng RenNaval Medical Center, Naval Medical University, Shanghai, 200433, China.
Feng MaSuzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, 215123, China.ORCID 0000-0002-2975-0118
Sheng XuNational Key Laboratory of Immunity & Inflammation, Naval Medical University, Shanghai, 200433, China.ORCID 0000-0002-9547-8052
Zhenzhen ZhanKey Laboratory of Arrhythmias of the Ministry of Education of China, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China. zhanzz2022@sjtu.edu.cn.
Xingguang LiuNational Key Laboratory of Immunity & Inflammation, Naval Medical University, Shanghai, 200433, China. liuxg@immunol.org.ORCID 0000-0002-1928-8847

Funding

National Natural Science Foundation of China (National Science Foundation of China) 82070415, 82371825National Natural Science Foundation of China (National Science Foundation of China) 82071790, 82271797, 82341065National Natural Science Foundation of China (National Science Foundation of China) 82201955
6 · The paper itself

Abstract

Spliceosome dysfunction and aberrant RNA splicing underline unresolved inflammation and immunopathogenesis. Here, we revealed the misregulation of mRNA splicing via the spliceosome in the pathogenesis of rheumatoid arthritis (RA). Among them, decreased expression of RNA binding motif protein 25 (RBM25) was identified as a major pathogenic factor in RA patients and experimental arthritis mice through increased proinflammatory mediator production and increased hyperinflammation in macrophages. Multiomics analyses of macrophages from RBM25-deficient mice revealed that the transcriptional enhancement of proinflammatory genes (including Il1b, Il6, and Cxcl10) was coupled with histone 3 lysine 9 acetylation (H3K9ac) and H3K27ac modifications as well as hypoxia inducible factor-1α (HIF-1α) activity. Furthermore, RBM25 directly bound to and mediated the 14

Indexed as

Arthritis, RheumatoidInflammationMacrophagesRNA-Binding ProteinsRNA SplicingAnimalsArthritis, ExperimentalATP Citrate (pro-S)-LyaseHumansMiceMice, Inbred C57BLMice, KnockoutSpliceosomesATP Citrate (pro-S)-LyaseRNA-Binding ProteinsAclyHistone acetylationInflammationMetabolic reprogrammingRBM25Splicing factor

Identifiers

PMID39251781
PMCPMC11527992

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.